Nervous System News and Research

Latest Nervous System News and Research

Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction

Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction

Air quality along US Gulf Coast improves after stoppage of oil leak

Air quality along US Gulf Coast improves after stoppage of oil leak

Ill effects of methamphetamine

Ill effects of methamphetamine

KemPharm receives patent for LAT prodrug technology for Attention Deficit – Hyperactivity Disorder treatment

KemPharm receives patent for LAT prodrug technology for Attention Deficit – Hyperactivity Disorder treatment

CeNeRx BioPharma raises $13 million through Series C financing to support TriRima Phase II trial

CeNeRx BioPharma raises $13 million through Series C financing to support TriRima Phase II trial

Catalyst second-quarter net loss decreases to $1,328,541

Catalyst second-quarter net loss decreases to $1,328,541

EUROPEAN BIOTECHNICA AWARD finalists announced

EUROPEAN BIOTECHNICA AWARD finalists announced

Neurologix second-quarter net loss increases to $4.5 million

Neurologix second-quarter net loss increases to $4.5 million

Study examines impact of microvascular decompression surgery for type 2 diabetes

Study examines impact of microvascular decompression surgery for type 2 diabetes

Tracking heart rate can provide important marker of health issues: Research

Tracking heart rate can provide important marker of health issues: Research

Aeterna Zentaris second-quarter revenues decrease to $5.6 million

Aeterna Zentaris second-quarter revenues decrease to $5.6 million

FDA advisory committee votes in favor of Ezogabine

FDA advisory committee votes in favor of Ezogabine

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon second-quarter net loss reduces to $5.7 million

Study finds lithium drugs not effective for amyotrophic lateral sclerosis treatment

Study finds lithium drugs not effective for amyotrophic lateral sclerosis treatment

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

NeoStem, Schepens Eye Research Institute collaborate to develop therapies for AMD and Glaucoma

NeoStem, Schepens Eye Research Institute collaborate to develop therapies for AMD and Glaucoma

Shire announces divestiture of Daytrana to Noven Pharmaceuticals

Shire announces divestiture of Daytrana to Noven Pharmaceuticals

OptiNose's bi-directional nasal device delivering fluticasone effective in reducing nasal polyps in CRS patients

OptiNose's bi-directional nasal device delivering fluticasone effective in reducing nasal polyps in CRS patients

Trigemina reports positive results from TI-001 Phase IIa clinical trial for Chronic Daily Headache

Trigemina reports positive results from TI-001 Phase IIa clinical trial for Chronic Daily Headache

StemCells second-quarter net loss decreases to $4.61 million

StemCells second-quarter net loss decreases to $4.61 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.